Allianz Asset Management
KRTX

Allianz Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Allianz Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,300
Closed -$7.06M – 2285
2023
Q4 		$7.06M Buy
22,300
+21,000
+1,615% +$4.08M 0.01% 799
2023
Q3 		$220K Hold
1,300
– – ﹤0.01% 2116
2023
Q2 		$282K Hold
1,300
– – ﹤0.01% 1849
2023
Q1 		$236K Buy
+1,300
New +$249K ﹤0.01% 2026
2022
Q3 		– Sell
-10,730
Closed -$1.36M – 2178
2022
Q2 		$1.36M Sell
10,730
-8,200
-43% -$942K ﹤0.01% 1566
2022
Q1 		$2.4M Sell
18,930
-339
-2% -$38.2K ﹤0.01% 1530
2021
Q4 		$2.52M Hold
19,269
– – ﹤0.01% 1518
2021
Q3 		$2.36M Buy
19,269
+27
+0.1% +$3.12K ﹤0.01% 1604
2021
Q2 		$2.19M Sell
19,242
-1,844
-9% -$216K ﹤0.01% 1441
2021
Q1 		$2.54M Sell
21,086
-7,730
-27% -$876K ﹤0.01% 1312
2020
Q4 		$2.93M Sell
28,816
-3,156
-10% -$292K ﹤0.01% 1208
2020
Q3 		$2.47M Sell
31,972
-4,491
-12% -$383K ﹤0.01% 1186
2020
Q2 		$4.06M Buy
36,463
+11,205
+44% +$974K ﹤0.01% 1302
2020
Q1 		$1.82M Buy
+25,258
New +$2.16M ﹤0.01% 1564

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Allianz Asset Management's KRTX Position: Q1 2024 in Review

Allianz Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 22,300 shares — an estimated $7.06M sold.

Allianz Asset Management first reported a position in KRTX in Q1 2020 and held it in 14 quarters. The position peaked at $7.06M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Allianz Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Allianz Asset Management sold 22,300 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $7.06M.
  • Allianz Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 14 quarters.
  • Allianz Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $7.06M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Allianz Asset Management's 13F filing for Q1 2024, filed 14 May 2024.